Loading clinical trials...
Loading clinical trials...
Clinical Concordance Evaluation of the T-SPOT®.TB Assay Performance Using Positive Selection With the T-Cell SelectTM Kit and Density Gradient Cell Isolation Methods
Conditions
Interventions
T-Cell SelectTM Kit
Locations
4
United States
NECCR Primacare Research, LLC
Fall River, Massachusetts, United States
Ohio State University
Columbus, Ohio, United States
University of Texas Health Science Center at Houston, School of Public Health in Brownsville
Brownsville, Texas, United States
Rapitrade
Cape Town, South Africa
Start Date
November 4, 2019
Primary Completion Date
March 18, 2020
Completion Date
March 18, 2020
Last Updated
March 3, 2022
NCT06192160
NCT05947890
NCT05989802
NCT06272812
NCT02354014
NCT04923958
Lead Sponsor
Oxford Immunotec
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions